K. Takabe
Molecular Biology · 2008–2019
A researcher in the Science corpus: 2 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 43 citations into it
Whom K. Takabe trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from K. Takabe's perspective
Ordered by how strongly the researchers K. Takabe trusts endorse each paper. Same corpus, a different order for every researcher.
- Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. (Journal of Clinical Investigation)
- Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists (Science)
- Sphingosine 1-Phosphate (S1P) Receptor Subtypes S1P1 and S1P3, Respectively, Regulate Lymphocyte Recirculation and Heart Rate* (Journal of Biological Chemistry)
- Oral fingolimod (FTY720) for relapsing multiple sclerosis. (New England Journal of Medicine)
- Essential Role for Sphingosine Kinases in Neural and Vascular Development (Molecular and Cellular Biology)
- The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors* (Journal of Biological Chemistry)
- Lymphocyte Sequestration Through S1P Lyase Inhibition and Disruption of S1P Gradients (Science)
- Biologically active sphingolipids in cancer pathogenesis and treatment (Nature Reviews. Cancer)
- SphK1 and SphK2, Sphingosine Kinase Isoenzymes with Opposing Functions in Sphingolipid Metabolism* (Journal of Biological Chemistry)
- Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1 (Nature)
Their papers
- “Inside-Out” Signaling of Sphingosine-1-Phosphate: Therapeutic Targets (2008) — 731 citations
- Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies. (2019) — 862 citations